A Study of AK0529 in Infants Hospitalized With RSV

Summary

This study will assess the safety, tolerability, pharmacokinetics (PK) and anti-viral effect of single dose of AK0529 in infants hospitalized with respiratory syncytial virus (RSV).

Timeline

Start

2015-08-28

Primary completion

2015-11-03

Completion

2015-11-03

Outcome

Outcome not reported

Stopped: “We switched this study design to another study per IEC's recommendations.”

Drugs

Indications